Page last updated: 2024-09-05

delta(9-11)-tetrahydrocannabinol and nalbuphine

delta(9-11)-tetrahydrocannabinol has been researched along with nalbuphine in 1 studies

Compound Research Comparison

Studies
(delta(9-11)-tetrahydrocannabinol)
Trials
(delta(9-11)-tetrahydrocannabinol)
Recent Studies (post-2010)
(delta(9-11)-tetrahydrocannabinol)
Studies
(nalbuphine)
Trials
(nalbuphine)
Recent Studies (post-2010) (nalbuphine)
1906793269185

Protein Interaction Comparison

ProteinTaxonomydelta(9-11)-tetrahydrocannabinol (IC50)nalbuphine (IC50)
Mu-type opioid receptorHomo sapiens (human)0.0578
Delta-type opioid receptorHomo sapiens (human)1.1195
Kappa-type opioid receptorHomo sapiens (human)0.097

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
France, CP; Maguire, DR1

Other Studies

1 other study(ies) available for delta(9-11)-tetrahydrocannabinol and nalbuphine

ArticleYear
Interactions between cannabinoid receptor agonists and mu opioid receptor agonists in rhesus monkeys discriminating fentanyl.
    European journal of pharmacology, 2016, Aug-05, Volume: 784

    Topics: Animals; Cannabinoid Receptor Agonists; Cyclohexanols; Discrimination, Psychological; Dronabinol; Drug Interactions; Female; Fentanyl; Macaca mulatta; Nalbuphine; Receptors, Opioid, mu

2016